Insmed Announces Lifting of Clinical Hold by FDA on Arikace

Insmed announced that the FDA has lifted the clinical hold previously placed on Arikace (liposomal amikacin for inhalation) in Cystic Fibrosis patients with Pseudomonas lung infections.
MarketWatch